Elizabeth Keatinge on Blogger: Published: Islet Antibodies and Type 1 Diabetes

Tuesday, January 4, 2022

Published: Islet Antibodies and Type 1 Diabetes

I published “Islet Antibodies and Type 1 Diabetes” on @Medium https://ift.tt/3FSiLy6

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

About Elizabeth Keatinge

Elizabeth “Libby” Keatinge Scheideler possesses an extensive background in journalism, writing, and broadcast media. Elizabeth Keatinge has reported from New York for several years.

Shortly after earning a bachelor’s in English from UCLA, she moved to New York City to take on a reporting and producing role with the New York Post. During this same period, she covered stories for MTV.

After stints with CBS and NBC news stations in Texas, Vermont, and Florida, Elizabeth Keatinge Scheideler returned to New York City, where she covered breaking news in Long Island, Queens, and Staten Island for FiOS1 News and NY1. Following her interest in business and finance, she started producing business news segments. As a business journalist, she covers topics such as cryptocurrency, women in entrepreneurship, and business funding.

Outside her work as a reporter and news content creator, Elizabeth “Libby” Keatinge is an active supporter of several local and international charitable organizations. She reads books aloud to children with the education-focused nonprofit Change for Kids, and has worked with the American Society for the Prevention of Cruelty to Animals. She supports organizations that address global issues such as human trafficking and orphaned children.

Elizabeth Keatinge on Blogger

Tuesday, January 4, 2022

Published: Islet Antibodies and Type 1 Diabetes

No comments:

Post a Comment

Published: NAWBO Highlights Middle Revenue Barrier for Women-led Businesses

Labels